VEGFA and ovarian carcinoma: To identify effective strategies to circumvent the mechanism by which ovarian cancer bypasses anti-VEGF therapy, we generated a xenograft model of antiangiogenic therapy resistance that closely mimics clinical resistance to ovarian cancer.